Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Bladder Cancer
100%
CYP2A6
100%
Cytochrome
75%
Protein Degradation
37%
Chemotherapy
37%
Drug Resistance
25%
Prodrug
25%
Malignant Neoplasm
12%
Carcinogen
12%
Chemoradiotherapy
12%
Chemosensitivity
12%
Non Muscle Invasive Bladder Cancer
12%
Bladder
12%
Cystectomy
12%
Androgen Receptor
12%
Targeted Therapy
12%
Health Care
12%
Tumor Invasion
12%
Quality of Life
12%
Health Care Cost
12%
Cancer Cell
12%
Survival Rate
12%
Ubiquitination
12%
Metabolic Activation
12%
Proteasome
12%
Cisplatin
12%
Immunoglobulin
12%
Estrogen Receptor
12%
Cancer
12%
Therapeutic Target
12%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2A6
100%
Bladder Cancer
100%
Cytochrome
75%
Chemotherapy Regimens
37%
Drug Resistance
25%
Prodrug
25%
Malignant Neoplasm
12%
Cisplatin
12%
Carcinogen
12%
Non Muscle Invasive Bladder Cancer
12%
Androgen Receptor
12%
Chemoradiation Therapy
12%
Immunoglobulin
12%
Estrogen Receptor
12%
Tumor Invasion
12%
Survival Rate
12%
Proteasome
12%
Undesired Effect
12%